Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01236079 · ClinicalTrials.gov registry record · NA
Cessation Service Use and Effectiveness for Hospitalized Smokers
A NA study of Smoking, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 900
- Enrollment target
- 3
- Study locations
NCT01236079 is a NA study of Smoking that has completed, run by Kaiser Permanente. The registered enrollment target is 900 participants, above the 448-participant average among 123 other Smoking trials with a reported enrollment target (101% higher). The trial reports 3 study locations across 1 state.
The verdict
NCT01236079, a NA study of Smoking, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this patient-randomized effectiveness trial is to demonstrate that an inpatient technology-supported assisted referral (I-TSAR) and follow-up approach is an effective and cost-effective method to help hospitalized patients successfully quit smoking. The proposed study represents a unique opportunity to assess the effectiveness and cost-effectiveness of linking inpatient and outpatient delivery of smoking cessation services in two large and very different health care delivery systems. We will enroll 900 participants (600 intervention, 300 controls) over 15-months and collect follow-up survey and health care utilization data over 12 months to estimate: 1) smoking abstinence at 6 and 12 months for I-TSAR intervention recipients compared to usual care; 2) the dose effect on smoking abstinence at 6 and 12 months for I-TSAR recipients compared to usual care; 3) total and mean costs per participant for I-TSAR and usual care recipients, and, if effective, estimate the incremental cost-effectiveness of the intervention vs. controls at 12 months from health plan/insurer and societal perspectives; and 4) differences in health care utilization at 12 months for I-TSAR versus controls.
Conditions Studied
Interventions
- BEHAVIORAL Assisted referral & IVR
Study Locations (3)
Oregon
- Kaiser Permanente Sunnyside - Clackamas
- Legacy Emanuel Hospital - Portland
- Oregon Health & Science Univeristy - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2011-12 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01236079
The ClinicalTrials.gov registry entry for NCT01236079 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 448-participant average among 123 other Smoking trials with a reported enrollment target (101% higher). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which Assisted referral & IVR is the first listed.
NCT01236079 reports 3 study locations spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT01236079 about?
NCT01236079 is a clinical study titled "Cessation Service Use and Effectiveness for Hospitalized Smokers". The goal of this patient-randomized effectiveness trial is to demonstrate that an inpatient technology-supported assisted referral (I-TSAR) and follow-up approach is an effective and cost-effective method to help hospitalized patients successfully quit smoking. The proposed study represents a unique...
What is the current status of trial NCT01236079?
This trial is currently completed. It is a NA study. The enrollment target is 900 participants. The study started on 2011-12. Estimated completion is 2016-07.
What conditions does trial NCT01236079 study?
This clinical trial studies the following conditions: Smoking.
What interventions are being tested in trial NCT01236079?
The interventions under investigation include: Assisted referral & IVR (BEHAVIORAL).
Who is sponsoring clinical trial NCT01236079?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01236079 being conducted?
This trial has 3 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
RECRUITING · NA
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.